Literature DB >> 9488046

Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.

A Greco1, L Fusetti, C Miranda, R Villa, S Zanotti, S Pagliardini, M A Pierotti.   

Abstract

The thyroid TRK-T3 oncogene results from the fusion of the tyrosine kinase (TK) domain of NTRK1 (one of the receptors for the Nerve Growth Factor) on chromosome 1 to sequences of a novel gene, TFG, on chromosome 3. The 68 kDa TRK-T3 fusion oncoprotein displays a constitutive tyrosine kinase activity resulting in its capability to transform mouse NIH3T3 cells. The TFG portion of TRK-T3 contains a coiled-coil domain most likely responsible for the constitutive, ligand-independent activation of the receptor tyrosine kinase activity. We have previously shown that TRK-T3 oncoprotein forms, in vivo, complexes of three or four molecules. By mean of different experimental approaches, we show here that TRK-T3 activity depends on oligomers formation. In addition, the analysis of different TRK-T3 mutants indicates that the TFG coiled-coil domain and its N-terminal region are both required for the activation and the fully transforming activity of the TRK-T3 oncoprotein, although, most likely, they play a role in different steps of the transforming process. The deletion of the coiled-coil domain abrogates the oligomers formation leading to a constitutive activation; the deletion of the N-terminal region, although not affecting phosphorylation and complexes formation, abrogates transformation, thus suggesting a role in cellular localization and/or interaction with substrata.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488046     DOI: 10.1038/sj.onc.1201596

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor.

Authors:  J C Arevalo; B Conde; B L Hempstead; M V Chao; D Martin-Zanca; P Perez
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry.

Authors:  Costel C Darie; Katrin Deinhardt; Guoan Zhang; Helene S Cardasis; Moses V Chao; Thomas A Neubert
Journal:  Proteomics       Date:  2011-10-28       Impact factor: 3.984

3.  Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.

Authors:  Luis Hernández; Sílvia Beà; Beatriz Bellosillo; Magda Pinyol; Brunangelo Falini; Antonino Carbone; German Ott; Andreas Rosenwald; Alberto Fernández; Karen Pulford; David Mason; Stephan W Morris; Eugenio Santos; Elias Campo
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

4.  Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure.

Authors:  Christian Beetz; Adam Johnson; Amber L Schuh; Seema Thakur; Rita-Eva Varga; Thomas Fothergill; Nicole Hertel; Ewa Bomba-Warczak; Holger Thiele; Gudrun Nürnberg; Janine Altmüller; Renu Saxena; Edwin R Chapman; Erik W Dent; Peter Nürnberg; Anjon Audhya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

Review 5.  Translocations in epithelial cancers.

Authors:  J Chad Brenner; Arul M Chinnaiyan
Journal:  Biochim Biophys Acta       Date:  2009-05-04

6.  ced-4 and proto-oncogene tfg-1 antagonistically regulate cell size and apoptosis in C. elegans.

Authors:  Ling Chen; Tom McCloskey; Pradeep M Joshi; Joel H Rothman
Journal:  Curr Biol       Date:  2008-07-22       Impact factor: 10.834

7.  Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure.

Authors:  A H Fischer; J A Bond; P Taysavang; O E Battles; D Wynford-Thomas
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

8.  Immunohistochemical Mapping of TRK-Fused Gene Products in the Rat Brainstem.

Authors:  Shigeko Takeuchi; Chiaki Masuda; Hisae Maebayashi; Ikuo Tooyama
Journal:  Acta Histochem Cytochem       Date:  2012-02-11       Impact factor: 1.938

9.  TFG-1 function in protein secretion and oncogenesis.

Authors:  Kristen Witte; Amber L Schuh; Jan Hegermann; Ali Sarkeshik; Jonathan R Mayers; Katrin Schwarze; John R Yates; Stefan Eimer; Anjon Audhya
Journal:  Nat Cell Biol       Date:  2011-04-10       Impact factor: 28.824

10.  TFG is required for autophagy flux and to prevent endoplasmic reticulum stress in CH12 B lymphoma cells.

Authors:  Tobit D Steinmetz; Ursula Schlötzer-Schrehardt; Abigail Hearne; Wolfgang Schuh; Jens Wittner; Sebastian R Schulz; Thomas H Winkler; Hans-Martin Jäck; Dirk Mielenz
Journal:  Autophagy       Date:  2020-09-22       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.